Advertiser / Brand
P&G vs Revolution Beauty
Structured technology and market comparison · 2026
Direct Feature Comparison
P&G · vs · Revolution BeautyGlobal consumer goods company selling household and personal care brands.
Public beauty brand selling makeup, skincare and haircare products.
Analyze all overlapping signals and tech stacks for P&G and Revolution Beauty
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between P&G and Revolution Beauty?
When comparing P&G and Revolution Beauty, both platforms operate within the Advertiser / Brand ecosystem. P&G is positioned as Global consumer goods company selling household and personal care brands, whereas Revolution Beauty focuses on Public beauty brand selling makeup, skincare and haircare products. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to P&G and Revolution Beauty?
When evaluating P&G and Revolution Beauty, enterprise buyers also consider other platforms in Advertiser / Brand. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of P&G and Revolution Beauty compare?
P&G is headquartered in US (founded in 1837) with >5,000 employees. Revolution Beauty is based in GB (founded in 2014) with 201–500 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: P&G vs Revolution Beauty
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
P&G
Recent Signals
- ·HorizontFinancials
US Ad Giants Cut Ad Spending Share to 5.5%
The WARC Global Ad Trends report titled 'The cost of being seen' analyzed the advertising-to-sales ratio of 25 major US advertisers, including Coca-Cola and P&G. The analysis reveals that the average ad-to-sales ratio has declined to 5.5%. This indicates a reduction in advertising intensity among large US corporations. Concurrently, WARC Media forecasts global ad spending to increase by 11.9% in 2026 to $1.34 trillion. The report highlights a strategic shift as brands allocate budgets more efficiently, possibly influenced by economic pressures and the need for greater ROI.
- WARC analyzed 25 major US advertisers including Coca-Cola and P&G.
- The average ad-to-sales ratio fell to 5.5%.
- WARC Media forecasts global ad spending to rise by 11.9% in 2026 to $1.34 trillion.
- ·SEC APIfinancials
8-K Financial Filing Analysis for P&G (2026-10-13)
On October 13, 2026, The Procter & Gamble Company announced via Form 8-K that its Board of Directors declared a quarterly dividend of $1.0885 per share on both its Common Stock and Series A and Series B ESOP Convertible Class A Preferred Stock. The dividend is scheduled for payment on or after November 16, 2026, to Common Stock shareholders of record as of the close of business on October 23, 2026, and to ESOP Preferred shareholders of record at the opening of business on the same date. Concurrently, the Company announced that preliminary voting results from its Annual Meeting of Shareholders confirmed the successful election of all twelve director nominees to the Board of Directors.
- Declared a quarterly dividend of $1.0885 per share on Common Stock and Series A and Series B ESOP Convertible Class A Preferred Stock.
- Set the dividend record date for October 23, 2026, with distributions payable on or after November 16, 2026.
- Confirmed the election of all twelve Director nominees to the Board of Directors based on preliminary Annual Meeting voting results.
- ·SEC APIfinancials
10-K Financial Filing Analysis for P&G (2026-08-04)
Procter & Gamble (P&G) reported its full-year financial results for the fiscal year ended June 30, 2026. Consolidated net sales increased 3% year-over-year to $87.03 billion, supported by 1% organic sales growth and a 2% favorable foreign exchange impact. Operating income decreased 3% to $19.75 billion due to a 100-basis-point decline in gross margin to 50.2% and higher marketing spending in SG&A. Net earnings rose slightly to $16.14 billion ($16.05 billion attributable to P&G), with diluted EPS improving 2% to $6.62, aided by share repurchases and non-operating gains including $261 million from the expiration and dissolution of the Glad joint venture interest. Operating cash flow remained strong at $19.56 billion, supporting $15.84 billion in adjusted free cash flow (100% productivity). The company continued executing its multi-year portfolio and productivity plan, incurring $903 million after tax in restructuring costs in fiscal 2026. P&G also announced an agreement on August 4, 2026, to acquire premium supplement brand Thorne for $3.8 billion.
- Net sales grew 3% to $87,032 million (organic sales up 1%), while net earnings attributable to P&G reached $16,046 million with diluted EPS of $6.62 (Core EPS of $6.89).
- Operating cash flow reached $19,556 million, delivering $15,835 million in adjusted free cash flow and achieving an adjusted free cash flow productivity rate of 100%.
- Subsequent to fiscal year-end on August 4, 2026, P&G signed an agreement to acquire premium wellness brand Thorne for $3.8 billion.
Revolution Beauty
Recent Signals
- ·SEC APIfinancials
8-K Financial Filing Analysis for Revolution Beauty (2026-08-19)
On August 17, 2026, the Compensation Committee of Revelation Biosciences, Inc. approved material restricted stock grants to executive leadership under its Amended and Restated 2021 Equity Incentive Plan. Chief Executive Officer James Rolke received 208,076 restricted shares, and Chief Financial Officer Chester S. Zygmont, III was granted 208,073 restricted shares. The equity awards are structured to vest across four equal 25% tranches linked to either reaching market capitalization hurdles of $30 million, $60 million, $90 million, and $120 million for 20 consecutive trading days, or time-based vesting at the two-year and four-year marks. The package aligns executive compensation with aggressive market valuation targets while providing retention security.
- CEO James Rolke and CFO Chester S. Zygmont, III were granted 208,076 and 208,073 restricted shares, respectively, under the 2021 Equity Incentive Plan.
- Awards vest in four equal 25% tranches upon reaching market capitalization thresholds of $30M, $60M, $90M, and $120M sustained over 20 consecutive trading days, or alternatively at 2-year (first two tranches) and 4-year (final two tranches) time intervals.
- Grants include standard accelerated vesting protections upon a Change in Control or qualified involuntary termination events.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners P&G and Revolution Beauty share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks